Help to interpret the results
The page contains two contents:
General: this table lists the KO entries and their description specific to this pathway, and provides their frequencies in Morganella psychrotolerans and in the whole dataset.
Profile + homologs: the distribution of the Kegg entries of Prostate cancer Kegg pathway is displayed here. Given a Kegg entry and a genome, a red box indicates that one or more loci have been annotated with, while a green box indicates that no locus/loci has(have) been annotated with it, but it/they is/are part of an Orthologous group in which other members have been annotated with that Kegg entry, so it is likely that this copy(ies) also performs this Kegg function.
Check the composition of the Prostate cancer pathway
| KO | Description | #in this genome | All occurrences |
|---|---|---|---|
| K00922 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153] | 0 | 0 |
| K01110 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [EC:3.1.3.16 3.1.3.48 3.1.3.67] | 0 | 0 |
| K01343 | tissue plasminogen activator [EC:3.4.21.68] | 0 | 0 |
| K01348 | urokinase plasminogen activator [EC:3.4.21.73] | 0 | 0 |
| K01351 | semenogelase [EC:3.4.21.77] | 0 | 0 |
| K01394 | matrix metalloproteinase-3 (stromelysin 1, progelatinase) [EC:3.4.24.17] | 0 | 0 |
| K01403 | matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35] | 0 | 0 |
| K02105 | catenin beta 1 | 0 | 0 |
| K02158 | Bcl-2-antagonist of cell death | 0 | 0 |
| K02161 | apoptosis regulator Bcl-2 | 0 | 0 |
| K02206 | cyclin-dependent kinase 2 [EC:2.7.11.22] | 0 | 0 |
| K02580 | nuclear factor NF-kappa-B p105 subunit | 0 | 0 |
| K02620 | transcription factor 7 | 0 | 0 |
| K02649 | phosphoinositide-3-kinase regulatory subunit alpha/beta/delta | 0 | 0 |
| K02833 | GTPase HRas | 0 | 0 |
| K03083 | glycogen synthase kinase 3 beta [EC:2.7.11.26] | 0 | 0 |
| K03099 | son of sevenless | 0 | 0 |
| K04079 | molecular chaperone HtpG | 1 | 7 |
| K04357 | epidermal growth factor | 0 | 0 |
| K04359 | platelet-derived growth factor subunit A | 0 | 0 |
| K04361 | epidermal growth factor receptor [EC:2.7.10.1] | 0 | 0 |
| K04362 | fibroblast growth factor receptor 1 [EC:2.7.10.1] | 0 | 0 |
| K04363 | platelet-derived growth factor receptor alpha [EC:2.7.10.1] | 0 | 0 |
| K04364 | growth factor receptor-bound protein 2 | 0 | 0 |
| K04365 | B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K04366 | RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K04368 | mitogen-activated protein kinase kinase 1 [EC:2.7.12.2] | 0 | 0 |
| K04369 | mitogen-activated protein kinase kinase 2 [EC:2.7.12.2] | 0 | 0 |
| K04371 | mitogen-activated protein kinase 1/3 [EC:2.7.11.24] | 0 | 0 |
| K04374 | cyclic AMP-dependent transcription factor ATF-4 | 0 | 0 |
| K04387 | interleukin 1 receptor type II | 0 | 0 |
| K04399 | caspase 9 [EC:3.4.22.62] | 0 | 0 |
| K04451 | tumor protein p53 | 0 | 0 |
| K04456 | RAC serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K04467 | inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10] | 0 | 0 |
| K04490 | transcription factor 7-like 1 | 0 | 0 |
| K04491 | transcription factor 7-like 2 | 0 | 0 |
| K04492 | lymphoid enhancer-binding factor 1 | 0 | 0 |
| K04498 | E1A/CREB-binding protein [EC:2.3.1.48] | 0 | 0 |
| K04503 | G1/S-specific cyclin-D1 | 0 | 0 |
| K04526 | insulin | 0 | 0 |
| K04734 | NF-kappa-B inhibitor alpha | 0 | 0 |
| K04735 | transcription factor p65 | 0 | 0 |
| K05083 | receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] | 0 | 0 |
| K05086 | insulin receptor-related receptor [EC:2.7.10.1] | 0 | 0 |
| K05087 | insulin-like growth factor 1 receptor [EC:2.7.10.1] | 0 | 0 |
| K05089 | platelet-derived growth factor receptor beta [EC:2.7.10.1] | 0 | 0 |
| K05093 | fibroblast growth factor receptor 2 [EC:2.7.10.1] | 0 | 0 |
| K05450 | platelet derived growth factor C/D | 0 | 0 |
| K05459 | insulin-like growth factor 1 | 0 | 0 |
| K05870 | cyclic AMP-responsive element-binding protein 1 | 0 | 0 |
| K06276 | 3-phosphoinositide dependent protein kinase-1 [EC:2.7.11.1] | 0 | 0 |
| K06618 | retinoblastoma-associated protein | 0 | 0 |
| K06620 | transcription factor E2F3 | 0 | 0 |
| K06624 | cyclin-dependent kinase inhibitor 1B | 0 | 0 |
| K06625 | cyclin-dependent kinase inhibitor 1A | 0 | 0 |
| K06626 | G1/S-specific cyclin-E1 | 0 | 0 |
| K06643 | E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27] | 0 | 0 |
| K07201 | forkhead box protein O1 | 0 | 0 |
| K07203 | serine/threonine-protein kinase mTOR [EC:2.7.11.1] | 0 | 0 |
| K07209 | inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] | 0 | 0 |
| K07210 | inhibitor of nuclear factor kappa-B kinase subunit gamma | 0 | 0 |
| K07827 | GTPase KRas | 0 | 0 |
| K07828 | GTPase NRas | 0 | 0 |
| K08557 | androgen receptor | 0 | 0 |
| K08774 | transforming growth factor, alpha | 0 | 0 |
| K08845 | A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] | 0 | 0 |
| K09047 | cyclic AMP-responsive element-binding protein 5 | 0 | 0 |
| K09048 | cyclic AMP-responsive element-binding protein 3 | 0 | 0 |
| K09299 | zinc finger homeobox protein 1 | 0 | 0 |
| K09348 | homeobox protein Nkx-3.1 | 0 | 0 |
| K09389 | transcription factor E2F2 | 0 | 0 |
| K09435 | transcriptional regulator ERG | 0 | 0 |
| K09487 | heat shock protein 90kDa beta | 0 | 0 |
| K09633 | transmembrane protease serine 2 [EC:3.4.21.122] | 0 | 0 |
| K12344 | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 [EC:1.3.1.22] | 0 | 0 |
| K15593 | ets translocation variant 5 | 0 | 0 |
| K15619 | Kunitz-type protease inhibitor 1 | 0 | 0 |
| K17386 | platelet-derived growth factor subunit B | 0 | 0 |
| K17454 | transcription factor E2F1 | 0 | 0 |
| K23790 | glutathione S-transferase P [EC:2.5.1.18] | 0 | 0 |